Notice of Intent to issue a Sole Source Award to Procure and Deliver Lateral Flow Test Results from Persons Administered Integrase Inhibitor-based Long-acting Pre-Exposure Prophylaxis (PrEP)

Inactive on SAM.gov — responses were due 23 Jul 2026 · No Set aside used · Centers for Disease Control and Prevention (CDC), HHS · Dallas, TX · NAICS 541715 · Solicitation 75D30126Q79102

Following NAICS 541715? Get new solicitations in it by email as they post — no account needed.

Email me new ones

What happened next

SAM.gov marked this notice inactive — responses were due 23 July 2026.

No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.

Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.

Solicitation details

Solicitation number75D30126Q79102
Notice IDd424ccd97941488faf2d68b1a900795f
AgencyDepartment of Health and Human Services (HHS)
Sub-agencyCenters for Disease Control and Prevention (CDC)
Contracting officeCDC OFFICE OF ACQUISITION SERVICES
NAICS code541715 — Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology)
Product / service code (PSC)AJ12
Set-asideNo Set aside used
Notice typePresolicitation
Posted08 July 2026
Response deadline23 July 2026 (closed)
Place of performanceDallas, TX, USA

Get new NAICS 541715 solicitations by email

This one has closed. We'll email you when new NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology)) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.

Description

The Centers for Disease Control and Prevention (CDC), Division of HIV Prevention requires an HIV care clinic within a public health network with a clientele of at least 50 persons on injectable cabotegravir long-acting (CAB-LA) (Apretude) pre-exposure prophylaxis (PrEP) for over 6 months. CAB-LA uptake is very low in the United States therefore having a sufficient number of participants on CAB-LA in one clinic to be able to successfully recruit at least 50 participants combined with serving a population with high transmission rates is key. The Dallas County Health and Human Services Sexual Health Clinic has a team of care providers and recognized leaders in HIV preventative care who can support investigation of new CDC-developed assays and manage requested blood spot specimen collection during care visits. This public health clinic incorporates the second-highest rate of sexually transmitted infection in the country with a high-frequency interaction with clientele to be able to recruit participant numbers and achieve the multiple-visit series of test evaluations within the contract period. No other provider has the combined capacity of recruiting persons with HIV or at increased risk of acquiring HIV, together with the high level of recognized expertise in long-acting PrEP care, and with experience in running Institutional Review Board (IRB)-approved protocols. The Dallas County Health Principal Investigaor (PI) is embedded in the patient care workflow to be able to effectively oversee recruiting and testing logistics. The Dallas County Health clinicians and care providers interact closely to manage the study aims, and they have available a nurse dedicated to ensuring evaluation testing and results upload for timely reporting and shipping of specimen to CDC. Dallas County health has th capability of successfully performing these clinical studies to satisfy CDC task orders and is currently the only identified source currently able to provide the required services to the CDC.This notice of intent is not a request for competitive quotations; however, all Quotations/ responses received within 15 days of the issuance of this notice shall be considered by the government. A determination by the government not to complete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist at email zvm0@cdc.gov by 07/23/2026.

Go deeper on this solicitation

FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.

Open the AI analysis in FedSift →

Free forever plan — no credit card. Browse solicitations without an account; sign in for AI analysis and matching.

Market context: HHS and NAICS 541715

About the buyer and the industry, not this specific solicitation. Source: USASpending.gov award data, updated nightly.

  • In fiscal year 2026, HHS obligated $406.8M across 212 contract actions under NAICS 541715.
  • 319 contracts worth $3.8B in this category end within the next 18 months.

HHS contracts under NAICS 541715 →

Other open solicitations in NAICS 541715

All NAICS 541715 solicitations →

More from Department of Health and Human Services

All HHS solicitations →

Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.

FedSift turns SAM.gov and USASpending data into federal BD intelligence — smart matches, recompete radar, cited AI solicitation analysis and compliance matrices.

Source data: SAM.gov (solicitations) and USASpending.gov (awards), refreshed nightly. FedSift is not affiliated with the U.S. Government.

Pricing · Privacy · Terms · support@fedsift.app